Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Best practice in the use of natalizumab in multiple sclerosis.
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
Management of worsening multiple sclerosis with mitoxantrone: a review.
Sex differences in autoimmune disease.
Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
TECFIDERA prescribing information
Origin, fate and dynamics of macrophages at central nervous system interfaces.
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination.
Demyelination of the hippocampus is prominent in the cuprizone model.
IL-2Rβγ-signaling contributes to regulatory T cell maintenance and stability in daclizumab HYP-treated RRMS patients
Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis
Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination.
FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective.
Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
Optical coherence tomography reflects brain atrophy in MS: A four year study.
Effects of dimethyl fumarate on neuroprotection and immunomodulation.
Experimental models of spontaneous autoimmune disease in the central nervous system.
Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.

Pages